Skip to content
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Cardiology

Heart-Hand Syndrome, Slovenian Type: A Patient Guide

At a Glance

Heart-Hand Syndrome, Slovenian type is a rare inherited LMNA condition that causes short fingers or toes and can lead to silent heart rhythm or muscle problems. Because heart risk varies and may increase with age, lifelong cardiology monitoring is essential.

Heart-Hand Syndrome, Slovenian type is an exceptionally rare genetic condition that primarily affects the development of the hands and the electrical health of the heart. It is defined by the co-occurrence of brachydactyly (noticeably short fingers or toes) and a potential for heart disease that often involves irregular heart rhythms and changes in the heart’s muscle [1]. Because this syndrome was identified in a single extended family and the overall evidence base is small, care is highly individualized. It is often managed by specialized teams who understand how these two seemingly different parts of the body are connected through a single genetic cause.

The condition is caused by a specific variation in the LMNA gene, known as the p.Arg335Trp variant [1]. This gene provides the instructions for proteins that act as a structural “scaffolding” for the nucleus of every cell in the body. Experimental research proposes that when this scaffolding is unstable, it can lead to cellular stress and damage over time, particularly in the heart [2][3]. The syndrome is inherited in an autosomal dominant pattern, meaning a parent with the variant has a 50% chance of passing it to each child [4].

One of the most important aspects of this syndrome is its variable expression. Even within the same family, some individuals may have prominent hand features but no heart issues, while others may have typical hands but develop significant heart rhythm problems [1]. This unpredictability means that heart risk cannot be predicted from hand appearance alone. Everyone who carries the genetic variant requires specialized medical attention, regardless of whether they “look” like they have the condition or feel any symptoms today.

While the hand features are present from birth and do not change, the heart features can be age-dependent and require lifelong monitoring [5][6]. The primary concern is the development of atrial arrhythmias (irregular heartbeats in the upper chambers), conduction blocks (slowing of the heart’s electrical signals), and potentially weakened heart muscle (dilated cardiomyopathy) [7][8]. Because these issues can emerge silently, check-ups with a cardiologist—including rhythm monitoring and heart imaging—are the most critical part of living with the condition [9][10].

Living with Heart-Hand Syndrome, Slovenian type means becoming an active partner in your own healthcare. While the long-term course can be uncertain, maintaining a specialized care team and a regular schedule of heart screenings reduces the chance of missing important changes. This proactive monitoring allows for timely interventions, supporting your long-term health and well-being [5][4].

Common questions in this guide

What is Heart-Hand Syndrome, Slovenian type?
Heart-Hand Syndrome, Slovenian type is a rare inherited condition that affects hand development and the heart’s electrical system and muscle. It is associated with short fingers or toes and can cause heart rhythm problems, conduction blocks, or a weakened heart muscle.
What genetic change is linked to this heart-hand syndrome?
The syndrome is linked to the p.Arg335Trp variant in the LMNA gene. Genetic testing can determine whether a person carries this variant, which can help guide heart monitoring and genetic counseling for relatives.
Can the appearance of someone’s hands predict their heart risk?
No. The condition has variable expression, so some people have noticeable hand features without heart problems, while others may have important heart problems with typical-looking hands. Hand appearance alone cannot show whether someone is at risk.
What heart problems can occur with this condition?
Possible heart problems include irregular rhythms from the upper chambers, slowing or blocking of the heart’s electrical signals, and weakening of the heart muscle known as dilated cardiomyopathy. These changes may develop with age and can sometimes be present without obvious symptoms.
How is Heart-Hand Syndrome, Slovenian type inherited?
Heart-Hand Syndrome, Slovenian type follows an autosomal dominant inheritance pattern. A parent who carries the LMNA variant has a 50% chance of passing it to each child, so genetic counseling and testing may be offered to relatives.
What heart monitoring does a person with this condition need?
People who carry the variant need ongoing follow-up with a cardiologist familiar with inherited heart conditions. Monitoring may include checks of heart rhythm and heart imaging because heart changes can develop silently and at different ages. The care team should explain how often testing is needed and whom to contact about new symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has our genetic testing confirmed the specific p.Arg335Trp variant associated with the Slovenian type?
  2. 2.What is the current status of my (or my child's) heart rhythm and atrial function based on recent tests?
  3. 3.How often should we be seen by a cardiologist who specializes in inherited heart conditions?
  4. 4.Which family members should be offered genetic counseling and testing?
  5. 5.Whom should we call, and at what number, if we notice new heart symptoms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Familial atrial myopathy in a large multigenerational heart-hand syndrome pedigree carrying an LMNA missense variant in rod 2B domain (p.R335W).

    Zhang Y, Lin Y, Zhang Y, et al.

    Heart rhythm 2022; (19(3)):466-475 doi:10.1016/j.hrthm.2021.11.022.

    PMID: 34808346
  2. 2

    Lamin A/C recruits ssDNA protective proteins RPA and RAD51 to stalled replication forks to maintain fork stability.

    Graziano S, Coll-Bonfill N, Teodoro-Castro B, et al.

    The Journal of biological chemistry 2021; (297(5)):101301 doi:10.1016/j.jbc.2021.101301.

    PMID: 34648766
  3. 3

    Lamin A/C facilitates DNA damage response by modulating ATM signaling and homologous recombination pathways.

    Kim SJ, Park SH, Myung K, Lee KY

    Animal cells and systems 2024; (28(1)):401-416 doi:10.1080/19768354.2024.2393820.

    PMID: 39176289
  4. 4

    Lamin A/C Cardiomyopathy: Implications for Treatment.

    Chen SN, Sbaizero O, Taylor MRG, Mestroni L

    Current cardiology reports 2019; (21(12)):160 doi:10.1007/s11886-019-1224-7.

    PMID: 31773301
  5. 5

    Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.

    Kumar S, Baldinger SH, Gandjbakhch E, et al.

    Journal of the American College of Cardiology 2016; (68(21)):2299-2307 doi:10.1016/j.jacc.2016.08.058.

    PMID: 27884249
  6. 6

    Contemporary Insights into LMNA Cardiomyopathy.

    Balakrishnan ID, Lakdawala NK

    Current cardiology reports 2025; (27(1)):40.

    PMID: 39869235
  7. 7

    Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants.

    Ferradini V, Cosma J, Romeo F, et al.

    Journal of clinical medicine 2021; (10(21)) doi:10.3390/jcm10215075.

    PMID: 34768595
  8. 8

    Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in Lamin A/C Cardiomyopathy.

    Tremblay-Gravel M, Ichimura K, Picard K, et al.

    Circulation. Genomic and precision medicine 2023; (16(1)):e003480 doi:10.1161/CIRCGEN.121.003480.

    PMID: 36548481
  9. 9

    Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy.

    Peretto G, Di Resta C, Perversi J, et al.

    Annals of internal medicine 2019; (171(7)):458-463 doi:10.7326/M18-2768.

    PMID: 31476771
  10. 10

    Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience.

    Forleo C, Carella MC, Basile P, et al.

    Biomedicines 2024; (12(6)) doi:10.3390/biomedicines12061293.

    PMID: 38927500

This page is for informational purposes only and does not constitute medical advice. Discuss genetic testing, heart screening, and symptoms with your cardiologist and genetics team.

Get notified when new evidence is published on Heart-hand syndrome, Slovenian type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.